This study furthers the evidence that Parkinson’s disease and type 2 diabetes share dysregulated molecular networks by identifying 84 shared genes, including SDO2, which is a potential biomarker for Parkinson’s and is known to interact with anti-diabetes drug therapies. 

READ FULL ARTICLE Curated publisher From PLOS ONE